 |
 |
Testosterone Treatment for Men and Women |
|
Both Men and Women need testosterone for optimal health. Testosterone is needed for libido, muscle strength, leanness, and sense of well being, cognitive function and mood.
Menopausal women have low to non-detectable testosterone levels with resultant loss of libido and increase in body fat. Return of libido and improved mood return within days of testosterone replacement by transdermal cream. Regrowth of muscle and bone occurs within months and is facilitated by a weight resistance training program.
The testosterone level in males peaks at age 17 and declines 1% per year thereafter. A middle-aged male can therefore have a testosterone level 40% below his peak in young adulthood. This problem can be compounded by the increased production of sex binding globulins, which make the lowered testosterone that is present even less effective. Loss of testosterone in males leads to atherosclerosis and heart attacks, obesity, fatigue, depression, and anxiety. These symptoms come on long before the male loses his sex drive or becomes impotent. There is no evidence that testosterone replacement therapy in males causes prostate cancer or prostate enlargement. In fact, some Urologist-Oncologists say that testosterone may decrease the incidence of prostatic hypertrophy and prostate cancer. CHI uses topical testosterone replacement as an essential part of its Hormone Replacement Theory (HRT) program for both men and women based on the patient's total and free testosterone levels and their levels of sex binding globulins. |
 |
Boosts male and female libido |
|
Facilitates a healthy heart |
|
Helps prevent osteoporosis |
|
Reduces total body fat |
|
Increases muscle strength, lean body mass |
|
Improves skin and body appearance |
|
| Testosterone References: |
Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC. Prostate 1995 Jul;27(1):25-31.
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.
There was no correlation of serum testosterone or free testosterone with prostate cancer
Cooper CS, MacIndoe JH, Perry PJ, Yates WR, Williams RD. J Urol 1996 Aug;156(2 Pt 1):438-41; discussion 441-2
The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men.
There was no increase in PSA when supplemental testosterone was used. |
| |
|
|
|
|
